Supernus Pharmaceuticals
SUPN
SUPN
223 hedge funds and large institutions have $1.4B invested in Supernus Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 74 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.36% more ownership
Funds ownership: 100.44% → 100.8% (+0.36%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 224 → 223 (-1)
Holders
223
Holding in Top 10
3
Calls
$3.33M
Puts
$911K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$8.25M | |
| 3 | +$7.73M | |
| 4 |
AC
Armistice Capital
New York
|
+$7.64M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$6.7M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$17.2M | |
| 3 | -$11.1M | |
| 4 |
Man Group
London,
United Kingdom
|
-$5.01M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.33M |